ACTRN12619000765123已完成2 期
Researching the Effectiveness of a nutraceuticaL Intervention for multiplE sclerosis-related Fatigue
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 117
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Aged 18-65 years;
- •Diagnosed with RRMS by a neurologist;
- •EDSS of less than 6 within last 12 months (measurement recorded in the absence of an acute relapse or illness);
- •English speaking or non-English speaking patients that can ensure external interpreter assistance (e.g. from a relative, spouse or friend) for the onsite clinical visits and for the phone follow-up timepoints.
- •On stable MS therapy for more than/ equal to 8 weeks prior to enrolment;
- •Available to attend clinic visits within 1 week of each time point (baseline, week 16, and week 20);
- •Clinical fatigue (as evidenced by a FSS score more than 4 on two occasions when completing the test serially online over a fortnight);
- •Basic confidence and literacy with using a computer (e.g. able to use web browser, receive SMS messages).
排除标准
- •Recent relapse of multiple sclerosis with onset within 12 weeks of recruitment interview
- •Known or suspected systemic medical disorder such as rheumatoid arthritis and kidney disease OR any medical condition (e.g. cognitive disorders, intellectual disability, Alzheimer’s disease) that investigators determine may affect participant adherence to the trial intervention
- •Previous cardiac events: angina, Coronary Artery Bypass Grafting (CABG), non- and ST elevated myocardial infarction (biotin can disrupt measurement of cardiac enzymes)
- •Currently prescribed thyroid-related medication (e.g. thyroxine) or diagnosed thyroid-related disorder
- •Pre-existing psychotropic therapy regimen needs to have been stable for 4 weeks prior to study entry
- •Pregnant or at risk of pregnancy (if female);
- •Current lactation;
- •Commenced or are scheduled to commence iron supplementation
- •Acute suicidality (score >1 on item 12 of a self-reported Quick Inventory of Depressive Symptomology Tool);
- •A current diagnosis of substance abuse/dependence;
- •Currently taking any illicit substances including any cannabis product (e.g. cannabis oil)
- •Recent gastrointestinal ulcers or renal stones;
- •Diagnosis of epilepsy;
- •Current use of any of the study preparations OR any multivitamin (eligible following a 3-week washout period);
- •Using > 200 mcg of selenium/day (antioxidant properties that are mechanistically similar to the study treatment).
- •Prescribed warfarin or phenytoin;
- •Allergy/intolerance to any study components;
- •No internet access or no access to computer/tablet or phone;
- •Unable or unlikely to attend the required study visits at the required timepoints or unable to complete the study protocol (e.g. upcoming travel, surgery)
- •Participant cannot be involved in any other interventional trial or study during the study period
- •Any other reason that the investigator team deems the individual to not be suitable for participation
研究者
相似试验
尚未招募
2 期
Assessment of effect of health supplements in healthy humans.CTRI/2024/03/064117HERBOLAB INDIA PVT LTD
已完成
Unknown
Exploring the benefits of grape pomace supplements for diabetic eye health: new clinical trial resultsImprovement of ophthalmic outcomes in patients with diabetic retinopathyEye DiseasesISRCTN15020073Inventia Biotech-Healthcare Food Research Center s.r.l.99
已完成
不适用
Study to investigate the nutritional efficacy and tolerance of an infant formula with an added synbiotic mixture in infantsHealthy infantsNutritional, Metabolic, EndocrineISRCTN23993517Danone Research B.V. (The Netherlands)228
招募中
不适用
A Study for evaluating the effectiveness of nutrition therapy in patients with cirrhosis with impaired glucose tolerance using continuous glucose monitoring and body composition analyzerCirrhosis with impaired glucose toleranceJPRN-UMIN000035952Hamamatsu University School of Medicine250
尚未招募
2 期
A trial to evidence based evaluation of the benefits of Nutri Bar a Multi Herbal Formulation, in Pandu Roga or IRON DEFICIENCY ANEMIA.CTRI/2017/12/010979CSIR Palampur